MIR29A, microRNA 29a, 407021

N. diseases: 278; N. variants: 0
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0239946
Disease: Fibrosis, Liver
Fibrosis, Liver
0.100 Biomarker disease BEFREE Here, we investigated the role of <i>MicroRNA29a (Mir29a)</i> in the resolution of liver fibrosis. 30781750 2019
CUI: C0239946
Disease: Fibrosis, Liver
Fibrosis, Liver
0.100 Biomarker disease BEFREE In this study, we asked whether miR-29a could reduce experimental high fat diet (HFD)-induced obesity and liver fibrosis in mice. 31652636 2019
CUI: C0239946
Disease: Fibrosis, Liver
Fibrosis, Liver
0.100 Biomarker disease BEFREE Therefore, the purpose of this study is to investigate the miR-29a regulation of BRD4 signaling in a bile duct-ligation (BDL) animal model with regard to developing cholestatic liver fibrosis. 30745801 2019
CUI: C0239946
Disease: Fibrosis, Liver
Fibrosis, Liver
0.100 Biomarker disease BEFREE This review focuses on the evolving view of the molecular mechanisms by which HSC activation by miR-29a signaling may moderate the profibrogenic phenotype of these cells, thus supporting the use of miR-29a agonists as a potential therapy for treating liver fibrosis in the future. 29954104 2018
CUI: C0239946
Disease: Fibrosis, Liver
Fibrosis, Liver
0.100 Biomarker disease BEFREE We have previously shown that microRNA-29a (miR-29a) protects against liver fibrosis. 29105510 2018
CUI: C0239946
Disease: Fibrosis, Liver
Fibrosis, Liver
0.100 Biomarker disease BEFREE In a previous study, we demonstrated that microRNA-29a (miR-29a) protects against liver fibrosis. 29366780 2018
CUI: C0239946
Disease: Fibrosis, Liver
Fibrosis, Liver
0.100 Biomarker disease BEFREE This study aims to investigate the effects of ARRB1 mediated by miR-29a and miR-652 on liver fibrosis and its possible mechanism. 28768954 2017
CUI: C0239946
Disease: Fibrosis, Liver
Fibrosis, Liver
0.100 Biomarker disease BEFREE MicroRNA-29a Alleviates Bile Duct Ligation Exacerbation of Hepatic Fibrosis in Mice through Epigenetic Control of Methyltransferases. 28106784 2017
CUI: C0239946
Disease: Fibrosis, Liver
Fibrosis, Liver
0.100 Biomarker disease BEFREE This study was conducted to clarify the mechanism of anti-fibrotic effect of miR-29a and to explore if miR-29a is a promising candidate for nucleic acid medicine against liver fibrosis. 27480597 2016
CUI: C0239946
Disease: Fibrosis, Liver
Fibrosis, Liver
0.100 Biomarker disease BEFREE Systemic Delivery of scAAV8-Encoded MiR-29a Ameliorates Hepatic Fibrosis in Carbon Tetrachloride-Treated Mice. 25923107 2015
CUI: C0239946
Disease: Fibrosis, Liver
Fibrosis, Liver
0.100 AlteredExpression disease BEFREE The down-regulation of miR-29a and miR-29b in male mouse livers correlated with the early development of liver fibrosis, as indicated by increased expressions of fibrotic markers in male mice relative to female mice. 22393047 2012